Émilie Cayssials

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau et al. · Clinical Cancer Research · 2019 · 108 citations · Full text

Evidence for eomesodermin‐expressing innate‐like CD8⁺ KIR/NKG2A⁺ T cells in human adults and cord blood samples

Florence Jacomet, Émilie Cayssials, Sara Basbous et al. · European Journal of Immunology · 2015 · 102 citations · Full text

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

Philippe Rousselot, Stéphane Prost, Joëlle Guilhot et al. · Cancer · 2016 · 91 citations · Full text

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

Damien Luque Paz, Rébecca Jouanneau‐Courville, Jérémie Riou et al. · Blood Advances · 2020 · 67 citations · Full text

Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases

Alice Barbarin, Émilie Cayssials, Florence Jacomet et al. · Frontiers in Immunology · 2017 · 66 citations · Full text

Adaptive Immune System, T-regulatory Cell, Cancer Diseases +21